Open original FDA record ↗Recall record
- FDA identifier
- Z-1223-2015
- Company in FDA record
- INO Therapeutics (dba Ikaria)
- FDA classification date
- Feb 27, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential delivery failure alarm condition. INOmax DSIR with software version 2.0.4 and a certain variant of the monitor display may trigger a delivery failure alarm when the display brightness is set to its lowest level. If this condition occurs, therapy will be interrupted.
Source facts
- Action
- Consignees were sent on 1/14/2015 an Ikaria "Urgent Field Correction Action" letter dated January 14, 2015. The letter described the problem and the product involved in the recall. The letter provided a number of recommendations to the consginees in regard to use and return of the product. For questions or adverse events they can contact Ikaria Customer Care at 1-877-KNOW-INO (1-877-566-9466) 24 hours a day, 7 days a week.
- Initiated
- 2015-01-14
- Root cause
- Process change control
- Terminated
- 2015-04-15
- Distribution
- Distribution US nationwide, including AZ, CA, CT, FL, ID, LA, MD, MI, MS, NH, NJ, NV, NY, OK, PA, TX, UT, VA, WV.
- Recall number
- Z-1223-2015
- Recall status
- Terminated
- CDRH record ID
- 133448
- FDA classified
- 2015-02-27
- Recall event number
- 70395